Extracellular Vesicles as Emerging Biomarkers in Infectious Diseases

Medical News: A new wave of scientific discovery is reshaping how infectious diseases are detected and understood. Researchers from the Barrow Neurological Institute at St. Joseph’s Hospital and Medical Center, the Department of Mechanical Engineering at Northern Arizona University, and the Norton Thoracic Institute have been studying the role of extracellular vesicles (EVs) in infectious diseases. These tiny particles, once thought to be mere cellular waste, are proving to be powerful biomarkers that could transform disease diagnosis and management.


Extracellular Vesicles as Emerging Biomarkers in Infectious Diseases

What Are Extracellular Vesicles
Extracellular vesicles are nanosized structures released by nearly all human cells. These vesicles serve as communication tools between cells, carrying a rich cargo of proteins, DNA, RNA, and metabolites. The specific composition of EVs depends on the health and condition of the cells that release them. They are present in various bodily fluids such as blood, urine, saliva, and even lung secretions, making them an accessible and non-invasive tool for medical diagnostics.
 
Scientists have discovered that EVs play a crucial role in the body's response to infections. They carry molecular signals that can help detect diseases early. This Medical News report explores how these vesicles could be used as diagnostic markers in bacterial, viral, and fungal infections, paving the way for faster and more precise medical interventions.
 
How Extracellular Vesicles Act as Biomarkers
When a person is infected with a pathogen, their cells release EVs that contain fragments of the infectious agent. These vesicles can include bacterial proteins, viral RNA, and immune system markers, providing a real-time snapshot of an ongoing infection. Researchers are developing methods to analyze EVs in bodily fluids to detect diseases such as tuberculosis, pneumonia, fungal infections, and even COVID-19.
 
One of the significant advantages of using EVs as biomarkers is that they provide a non-invasive diagnostic option. Traditional methods, such as blood tests and tissue biopsies, can be painful and slow. In contrast, EVs can be collected from easily accessible fluids and analyzed using advanced molecular biology techniques. This could allow doctors to detect infections earlier than ever before, improving patient outcomes and preventing disease spread.
 
Extracellular Vesicles in Bacterial Infections
Bacterial infections remain a major global health challenge, causing millions of deaths annually. Studies show that bacteria release their own EVs, known as outer membrane vesicles (OMVs), which play a role in infection and immune system modulation. For example, Mycobacterium tuberculosis, the bacteria responsible for tuberculosis, releases EVs that carry molecules capable of influencing the immune response. These vesicles could be used to identify tuberculosis cases more quickly and accurately than traditional sputum tests.
 
A nother bacterial species, Pseudomonas aeruginosa, produces EVs that contain virulence factors. These factors help the bacteria evade the immune system and establish infections, especially in patients with weakened immune defenses. By analyzing these bacterial EVs, doctors may be able to predict infection severity and tailor treatments accordingly.
 
Extracellular Vesicles in Viral Infections
Viruses, including influenza, HIV, and SARS-CoV-2 (the virus responsible for COVID-19), also interact with extracellular vesicles. Some viruses use EVs to spread from cell to cell, hiding from the immune system in the process.
 
Researchers have found that SARS-CoV-2-infected cells release EVs carrying viral proteins even before symptoms appear. This discovery could lead to EV-based tests capable of detecting infections much earlier than standard PCR tests.
In lung transplant patients, scientists have found that EVs contain viral antigens, which can be used to monitor post-transplant infections. Understanding how EVs carry and distribute viral particles could improve our ability to diagnose and treat infections more effectively.
 
Extracellular Vesicles in Fungal Infections
Fungal infections are often difficult to diagnose due to their slow progression and deep tissue invasion. Researchers have discovered that fungi such as Candida albicans release EVs that carry immune-activating molecules. These vesicles may help the fungus evade the immune system or trigger excessive inflammation. By identifying fungal EVs in blood or saliva, doctors may be able to diagnose fungal infections earlier and more accurately.
 
Challenges in Using Extracellular Vesicles as Biomarkers
Despite the promise of EVs as diagnostic tools, several challenges remain. One major issue is the difficulty of isolating and analyzing these tiny vesicles. Current laboratory techniques require specialized equipment and expertise, making EV-based tests difficult to implement in routine clinical settings. Another challenge is the variability of EV composition depending on the patient’s health status, which complicates standardization.
 
However, researchers are working on solutions to make EV analysis more practical for widespread use. Advances in nanotechnology and machine learning are helping scientists refine EV detection methods, bringing us closer to a future where EV-based diagnostics are part of routine medical practice.
 
Conclusion
Extracellular vesicles have emerged as a promising new tool in the fight against infectious diseases. Their ability to carry disease-related molecules offers a unique, non-invasive approach to diagnosing bacterial, viral, and fungal infections. While challenges remain, ongoing research is rapidly advancing our understanding of how EVs can be used for early detection and personalized treatment strategies. As these discoveries continue to unfold, the medical community may soon have access to a powerful new method for detecting and managing infectious diseases.
 
The study findings were published in the peer-reviewed journal: Biology.
https://www.mdpi.com/2079-7737/14/2/182
 
For the latest on Extracellular vesicles, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/stem-cell-derived-vesicles-as-a-new-hope-for-stroke-recovery
 
https://www.thailandmedical.news/news/prenatal-sars-cov-2-infection-and-its-effects-on-human-milk-extracellular-vesicles
 
https://www.thailandmedical.news/news/kinases-in-extracellular-vesicles-of-hiv-infected-cells-impact-bystander-cells
 
https://www.thailandmedical.news/pages/thailand_doctors_listings
 
https://www.thailandmedical.news/articles/hospital-news